Literature DB >> 11090054

Differential stimulation of c-Kit mutants by membrane-bound and soluble Steel Factor correlates with leukemic potential.

J L Gommerman1, D Sittaro, N Z Klebasz, D A Williams, S A Berger.   

Abstract

The authors investigated the roles of PI3-kinase and PLC-gamma in stimulation by Steel Factor (SLF) through c-Kit. c-Kit mutants YF719, YF728, and a YF719/YF728 double mutant were expressed in 32D myelomonocytic cells. KitYF719 fails to recruit PI3-kinase after stimulation with SLF, whereas KitYF728 fails to stimulate PLC-gamma phosphorylation or mobilize Ca(++). Both single mutants responded mitogenically to soluble SLF (sSLF) in a manner indistinguishable from wild type (WT), although sSLF failed to stimulate or promote the survival of cells expressing the double mutant. In contrast, although cells expressing WT or YF719 were mitogenically stimulated by membrane-bound SLF (mSLF), stimulation of cells expressing KitYF728 was impaired. Similarly, cells expressing WT or YF719 receptors were stimulated by plate-bound anti-Kit antibodies, whereas cells expressing the YF728 receptor were not stimulated. Neomycin sulfate, a PLC antagonist, inhibited cells expressing YF719 receptors stimulated by sSLF. Neomycin also inhibited cells expressing the WT receptor that were stimulated by mSLF or immobilized anti-Kit antibodies but did not inhibit stimulation of cells expressing WT or YF719 receptors by sSLF. 32D cells expressing KitWT, KitYF719, or KitYF728 were injected into mice and the presence of cells was evaluated by colony assays 6 to 7 weeks later. Although both KitWT and KitYF719 expressing cells could be recovered from the spleen and bone marrow, recovery of KitYF728 cells from these organs was severely reduced. These results indicate that Kit tyrosine 728 is of particular importance for mitogenic stimulation by mSLF or immobilized ligand and is required for full maintenance of cells in vivo, likely through activation of PLC-gamma. (Blood. 2000;96:3734-3742)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090054

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  c-Kit-mediated overlapping and unique functional and biochemical outcomes via diverse signaling pathways.

Authors:  Li Hong; Veerendra Munugalavadla; Reuben Kapur
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Selective deletion of the membrane-bound colony stimulating factor 1 isoform leads to high bone mass but does not protect against estrogen-deficiency bone loss.

Authors:  Gang-Qing Yao; Jian-Jun Wu; Nancy Troiano; Mei-Ling Zhu; Xiao-Yan Xiao; Karl Insogna
Journal:  J Bone Miner Metab       Date:  2011-11-23       Impact factor: 2.626

3.  The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.

Authors:  Henrique J Cardoso; Marília I Figueira; Sílvia Socorro
Journal:  J Cell Commun Signal       Date:  2017-06-27       Impact factor: 5.782

Review 4.  Signaling pathways influencing SLF and c-kit-mediated survival and proliferation.

Authors:  Stuart A Berger
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 5.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

6.  KIT associated intracellular tyrosines play an essential role in EpoR co-signaling.

Authors:  Li Hong; Baskar Ramdas; Jinbiao Chen; Chad Harris; Don M Wojchowski; Reuben Kapur
Journal:  Cell Signal       Date:  2008-04-15       Impact factor: 4.315

7.  A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis.

Authors:  Valter Agosti; Vinit Karur; Pradeep Sathyanarayana; Peter Besmer; Don M Wojchowski
Journal:  Exp Hematol       Date:  2008-12-18       Impact factor: 3.084

8.  Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease.

Authors:  Peilin Ma; Raghuveer Singh Mali; Holly Martin; Baskar Ramdas; Emily Sims; Reuben Kapur
Journal:  Leukemia       Date:  2012-02-02       Impact factor: 11.528

Review 9.  Gastrointestinal stromal tumor and its targeted therapeutics.

Authors:  Jheri Dupart; Wei Zhang; Jonathan C Trent
Journal:  Chin J Cancer       Date:  2011-05

10.  C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways.

Authors:  Bathri N Vajravelu; Kyung U Hong; Tareq Al-Maqtari; Pengxiao Cao; Matthew C L Keith; Marcin Wysoczynski; John Zhao; Joseph B Moore; Roberto Bolli
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.